NCT05982925

Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders

Recruiting
Not specifiedAges 18+Observational
Icahn School of Medicine at Mount Sinai
~170 participants
Updated 2026-06-15 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cortical Lesion Number
Measured over at 6 years (end of study)
Multiple Sclerosis
Neuromyelitis Optica
Demyelinating Autoimmune Diseases, CNS
1 sites across 1 states
New York1
  • Erin S Beck, MD, PhD · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years old
able to provide consent in English
able to undergo MRI

Exclusion

contraindication to MRI
pregnancy
  • Cortical Lesion Numberat 6 years (end of study)

    Lesions in the cerebral cortex